Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8017121
APP PUB NO 20010001663A1
SERIAL NO

09756125

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

There is provided a synovial cell growth inhibitor, or a pharmaceutical composition for treatment of chronic rheumatoid arthritis based on the synovial cell growth inhibitor.The pharmaceutical composition for treatment of chronic rheumatoid arthritis or synovial cell growth inhibitor contains an IL-6 antagonist, such as IL-6 antibody or IL-6R antibody, as an effective component.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
CHUGAI SEIYAKU KABUSHIKI KAISHATOKYO324
KISHIMOTO, TADAMISTUTOKYO, JP0

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kishimoto, Tadamitsu Tondabayashi, JP 46 937
Mihara, Masahiko Gotenba, JP 13 335
Moriya, Yoichiro Gotenba, JP 3 178
Ohsugi, Yoshiyuki Gotenba, JP 11 229

Cited Art Landscape

Patent Info (Count) # Cites Year
 
Other [Check patent profile for assignment information] (3)
5670373 Antibody to human interleukin-6 receptor 74 1994
5851793 Recombinant DNA encoding receptor protein for human B-cell stimulatory factor-2 16 1995
6428979 Receptor protein for human B cell stimulatory factor-2 17 1999
 
Tadamitsu Kishimoto (2)
5888510 Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component 99 1997
6723319 Method of treating inflammatory intestinal diseases containing as the ingredient IL-6 receptors antibodies 67 2000
 
CHIRON CORPORATION (1)
5591827 Interleukin-6 receptor antagonists 21 1994
 
Immunotech (1)
5559012 Therapeutic, IL-6 antibody kits, and process for their preparation 41 1994
 
TANABE SEIYAKU CO., LTD. (1)
5210075 Interleukin 6 antagonist peptides 28 1990
 
CHUGAI SEIYAKU KABUSHIKI KAISHA (3)
2002/0187,150 Preventive and/or therapeutic agent for systemic lupus erythematosus comprising anti-IL-6 receptor antibody as an active ingredient 24 2002
2004/0115,197 Remedies for infant chronic arthritis-relating diseases 41 2003
2006/0292,147 Blood MMP-3 level-lowering agent comprising IL-6 antagonist as active ingredient 63 2006
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
F. HOFFMANN-LA ROCHE AG (1)
8568720 High concentration antibody-containing liquid formulation 3 2008
 
ROBERT BOSCH GMBH (1)
4974745 Pressure compensating element for electrical device enclosure 5 1989
 
SIEMENS AKTIENGESELLSCHAFT (1)
5184102 Housing for an electromechanical component, particularly for a relay 3 1991
 
HOFFMANN-LA ROCHE INC. (3)
* 2011/0117,087 METHOD FOR THE PRODUCTION OF A GLYCOSYLATED IMMUNOGLOBULIN 10 2010
8580264 Subcutaneously administered anti-IL-6 receptor antibody 3 2011
9539263 Subcutaneously administered anti-IL-6 receptor antibody for treatment of systemic sclerosis 0 2013
 
TYCO ELECTRONICS LOGISTICS AG (1)
4907126 Housing for an electrical component, particularly for a relay 3 1988
 
JANSSEN BIOTECH, INC. (1)
* 2012/0096,569 ANTI-IL-6 ANTIBODIES,COMPOSITIONS, METHODS AND USES 15 2011
 
MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (2)
6388975 Mechanism for loading disk into disk drive apparatus 0 1998
6434101 Optical storage device and cartridge holding mechanism 1 1999
 
CHUGAI SEIYAKU KABUSHIKI KAISHA (9)
8840884 Antibody-containing solution pharmaceuticals 3 2003
8398980 Subtypes of humanized antibody against interleuken-6 receptor 6 2005
* 2010/0247,523 Subtypes of humanized antibody against interleuken-6 receptor 14 2005
9017677 Methods of treating a disease mediated by sensitized T cells 1 2006
9051384 Antibody-containing solution formulations 1 2009
* 2009/0131,639 ANTIBODY-CONTAINING SOLUTION FORMULATIONS 15 2009
8709409 Method for treating rheumatoid arthritis by administering an anti-IL-6 antibody and methotrexate 3 2009
9255145 Therapeutic agent for chronic arthritides diseases of childhood-related diseases 0 2011
8734800 Subtypes of humanized antibody against interleukin-6 receptor 3 2012
* Cited By Examiner

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 13, 2019
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 13, 2023
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00